Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride Capsule
Product Images NDC 61269-386

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride (NDC 61269-386). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

61269-386-12-blister (61269 386 12 Blister)

61269-386-12-blister (61269 386 12 Blister)
The text provides information about Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Hydrochloride Capsules. Each capsule contains specific quantities of the three ingredients. The recommended dosage is to take 3 capsules four times a day. The text also includes details on how to access the full prescribing information and directions for use. Additionally, it mentions a distributor, H2-Pharma, LLC based in Montgomery, AL, along with a National Drug Code (NDC) number. Reminder to peel the paper at the arrow to access the capsules.*
FDA Label Image

61269-386-12-carton (61269 386 12 Carton)

61269-386-12-carton (61269 386 12 Carton)
The text provides information about a medication in the form of capsules containing bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride. The capsules are intended for a 10-day therapy package and are designed for the eradication of Helicobacter pylori. The medication is stored at controlled room temperature, and caution should be taken as indicated. This therapy is specifically targeted for patients with Helicobacter pylori infection and duodenal ulcer disease. Please consult your prescribing information and healthcare provider for more details.*
FDA Label Image

Metronidazole (Metronidazole)

FDA Label Image

Tetracycline Hydrochloride (Tetracycline Hydrochloride)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.